Key result
SR-BI-deficient mice had a significantly reduced time to total arterial occlusion compared to wild-type mice (13±1 vs 24±2 minutes, P=0.02), indicating increased thrombosis susceptibility.
Why the study?
Does SR-BI deficiency increase thrombosis susceptibility and alter platelet function in mice?
Does SR-BI deficiency increase thrombosis susceptibility and alter platelet function in mice?
Absolute Event Rate: 13% vs 24%
p-value: p=0.02
SR-BI deficiency in mice indirectly increases thrombosis susceptibility and alters platelet function by elevating plasma free cholesterol.
OBJECTIVE: Scavenger receptor BI (SR-BI) is a cell surface receptor that promotes the selective uptake of cholesteryl esters from high-density lipoprotein (HDL) by the liver. In mice, SR-BI deficiency results in increased plasma HDL cholesterol levels and enhanced susceptibility to atherosclerosis. The aim of this study was to investigate the role of SR-BI deficiency on platelet function. METHODS AND RESULTS: SR-BI-deficient mice were thrombocytopenic, and their platelets were abnormally large, probably because of an increased cholesterol content. The FeCl(3) acute injury model to study arterial thrombosis susceptibility showed that SR-BI wild-type mice developed total arterial occlusion after 24±2 minutes. In SR-BI-deficient mice, however, the time to occlusion was reduced to 13±1 minutes (P=0.02). Correspondingly, in SR-BI-deficient mice, platelets circulated in an activated state and showed increased adherence to immobilized fibrinogen. In contrast, platelet-specific disruption of SR-BI by bone marrow transplantation in wild-type mice did not alter plasma cholesterol levels or affect platelet count, size, cholesterol content, or reactivity, suggesting that changes in plasma cholesterol levels were responsible for the altered responsiveness of platelets in SR-BI-deficient mice. CONCLUSIONS: The function of SR-BI in HDL cholesterol homeostasis and prevention of atherosclerosis is indirectly also essential for maintaining normal platelet function and prevention of thrombosis.
No takes yet. Share an insight, caveat, or question.
Korporaal et al. (2010) studied Thrombosis susceptibility. SR-BI deficiency vs. SR-BI wild-type mice was evaluated on Time to total arterial occlusion in the FeCl(3) acute injury model (p=0.02). SR-BI-deficient mice had a significantly reduced time to total arterial occlusion compared to wild-type mice (13±1 vs 24±2 minutes, P=0.02), indicating increased thrombosis susceptibility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: